Inpatient Care - Singapore | Statista Market Forecast

In Singapore, the Inpatient Care market is anticipated to witness a significant increase in revenue, reaching a projected value of US$6.38bn by 2024.
It is expected to maintain a steady growth rate with a compound annual growth rate (CAGR 2024-2029) of 5.96%, leading to a market volume of US$8.52bn by 2029.
In terms of global comparison, United States is predicted to generate the highest revenue in the Inpatient Care market sector, amounting to US$731.40bn in 2024.
Singapore's inpatient care market is known for its advanced medical technology and high quality healthcare services.

Definition:
Inpatient Care refers to medical and surgical services provided to patients who are admitted for overnight stays at hospitals. This market covers a wide range of services, such as diagnostics, medical treatments, and surgical treatments. It also includes facilities, nursing care, and other services that are necessary for the patient's recovery and well-being during their hospital stay. However, inpatient long-term care (LTC) for people with LTC needs is not included. Hospital inpatient care is a crucial component of the healthcare industry and is essential for providing high-quality and comprehensive medical care to patients.

Structure:
Inpatient Care covers Neoplasm Treatments, Treatments of Cardiovascular Diseases, Treatments of Musculoskeletal Diseases, Gastroenterology, Midwifery, and Other Inpatient Care. Other Inpatient Care provides information on additional areas that are not covered by the previously mentioned markets.

Additional information:
Inpatient Care comprises revenues, average revenue per capita, number of hospitals, average revenue per hospital, number of hospital beds, and average revenue per hospital bed. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Inpatient nursing care
Medical goods for inpatient treatments
Inpatient surgical treatments

Day care
Long-term care
Outpatient care
Home-based care

The Inpatient Care market in Singapore has been experiencing significant growth in recent years, driven by various factors such as an aging population and rising healthcare expenditure.

Customer preferences: Patients in Singapore have a strong preference for high-quality medical care and facilities, which has led to an increase in demand for private hospitals and medical centers. In addition, there is a growing trend towards medical tourism, with patients from neighboring countries seeking treatment in Singapore due to its reputation for excellent healthcare services.

Trends in the market: One of the key trends in the Inpatient Care market in Singapore is the increasing adoption of technology in healthcare. This includes the use of electronic medical records, telemedicine, and other digital solutions that improve patient care and outcomes. Another trend is the shift towards value-based care, which focuses on improving patient outcomes while reducing costs.

Local special circumstances: Singapore has a well-developed healthcare infrastructure, with a strong emphasis on preventative care and disease management. The government has implemented various policies and initiatives to improve healthcare access and affordability for its citizens, including the introduction of universal healthcare coverage. In addition, the country has a highly-educated and skilled healthcare workforce, which has helped to drive innovation and improve patient outcomes.

Underlying macroeconomic factors: The Inpatient Care market in Singapore is influenced by various macroeconomic factors, including demographic trends, healthcare expenditure, and government policies. The country has an aging population, which has led to an increase in chronic diseases and a higher demand for healthcare services. Healthcare expenditure has also been rising, driven by both public and private spending. Finally, government policies and initiatives have played a key role in shaping the healthcare landscape in Singapore, with a focus on improving access, affordability, and quality of care.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The healthcare landscape in the United States is a complicated one. There are federal health insurance plans for low-income individuals namely Medicaid and CHIP (Children’s health insurance program) and Medicare for seniors and the disabled. Aside from these, people must buy private health insurance or be left uninsured because the U.S. is the only high-income country without universal healthcare coverage. Hospitals in the U.S., therefore, receive payment from multiple payers. Most revenue generated by U.S. hospitals comes from private insurance, self, or other payments. The complexity of this multi-payer system is instrumental to the U.S. having the highest administrative health costs per capita among wealthy nations.